Bolus anti-thymocyte globulin induction in renal transplant recipients: a comparison with conventional ATG or anti-interleukin-2 receptor antibody induction

By Nampoory M.R.N.   Abdulhalim M.   Johny K.V.   Al-Jawad Donia F.A.   Nair M.P.   Said T.   Homoud H.   Samhan M.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2916-2919

Elsevier

Access to resources Recommend Favorite

Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

By Cantarovich M.   Quantz M.   Elstein E.   Ergina P.   Magnan C.   de Varennes B.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 446-448

Elsevier

Access to resources Recommend Favorite

Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction

By Cantarovich M.   de Gruchy S.   Forbes C.   Marpole D.   Elstein E.   Magnan C.   de Varennes B.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 79-79

Elsevier

Access to resources Recommend Favorite

Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients

By Abou-Jaoude M.M.   Ghantous I.   Najm R.   Afif C.   Almawi W.Y.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2731-2732

Elsevier

Access to resources Recommend Favorite

Clinical Significance of T Cell Monitoring During Antithymocyte Globulin Induction in Renal Transplantation

By Thervet E.   Chatenoud L.   Legendre C.   Mamzer-Bruneel M.-F.   Kreis H.   Bach J.F.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2330-2331

Elsevier

Access to resources Recommend Favorite